van de Velde CJH - Search Results

1

Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.

Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, Liefers GJ, Nortier JWR, Rutgers EJT, Seynaeve CM, van de Velde CJH; IDEAL and TEAM Study Groups. Blok EJ, et al. Among authors: van de velde cjh. Eur J Cancer. 2018 May;95:59-67. doi: 10.1016/j.ejca.2018.03.014. Epub 2018 Apr 7. Eur J Cancer. 2018. PMID: 29635145 Clinical Trial.

2

Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer.

Kiebert GM, Hanneke J, de Haes CJ, Kievit J, van de Velde CJ. Kiebert GM, et al. Eur J Cancer. 1990;26(10):1038-42. doi: 10.1016/0277-5379(90)90046-v. Eur J Cancer. 1990. PMID: 2148877 Clinical Trial.

3

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.

Beerman H, Kluin PM, Hermans J, van de Velde CJ, Cornelisse CJ. Beerman H, et al. Int J Cancer. 1990 Jan 15;45(1):34-9. doi: 10.1002/ijc.2910450108. Int J Cancer. 1990. PMID: 2298504

4

Treatment of colorectal cancer metastases confined to the liver.

Vahrmeijer AL, van Dierendonck JH, van de Velde CJ. Vahrmeijer AL, et al. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1238-42. doi: 10.1016/0959-8049(95)00214-4. Eur J Cancer. 1995. PMID: 7577030 Review.

5

Preoperative chemotherapy in operable breast cancer. The influence of timing FEC in relation to surgery.

van de Velde CJ. van de Velde CJ. Drugs. 1993;45 Suppl 2:31-7; discussion 36-7. doi: 10.2165/00003495-199300452-00006. Drugs. 1993. PMID: 7693419 Review.

6

Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.

Tollenaar RA, Liefers GJ, Repelaer van Driel OJ, van de Velde CJ. Tollenaar RA, et al. Eur J Cancer. 1994;30A(10):1448-53. doi: 10.1016/0959-8049(94)00280-i. Eur J Cancer. 1994. PMID: 7833100 Review.

7

Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.

Clahsen PC, van de Velde CJ, Julien JP, Floiras JL, Delozier T, Mignolet FY, Sahmoud TM. Clahsen PC, et al. J Clin Oncol. 1996 Mar;14(3):745-53. doi: 10.1200/JCO.1996.14.3.745. J Clin Oncol. 1996. PMID: 8622020 Clinical Trial.

8

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy.

van Slooten HJ, Clahsen PC, van Dierendonck JH, Duval C, Pallud C, Mandard AM, Delobelle-Deroide A, van de Velde CJ, van de Vijver MJ. van Slooten HJ, et al. Br J Cancer. 1996 Jul;74(1):78-85. doi: 10.1038/bjc.1996.319. Br J Cancer. 1996. PMID: 8679463 Free PMC article. Clinical Trial.

9

Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer.

Songun I, Bonenkamp JJ, Hermans J, van Krieken JH, van de Velde CJ. Songun I, et al. Eur J Cancer. 1996 Mar;32A(3):433-7. doi: 10.1016/0959-8049(95)00591-9. Eur J Cancer. 1996. PMID: 8814687

10

Micrometastases and survival in stage II colorectal cancer.

Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Liefers GJ, et al. N Engl J Med. 1998 Jul 23;339(4):223-8. doi: 10.1056/NEJM199807233390403. N Engl J Med. 1998. PMID: 9673300 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

906 results

Search Page